In University of Dundee we have two dedicate screening units, i.e. SCILLS and DDU. 

SCILLS at University of Dundee is dedicated to the study of how biological processes are controlled and how they become deregulated in disease. The Protein Ubiquitylation is the institute’s first research Division. Its major aims are to advance understanding of the role of protein ubiquitylation and related modifications in cell regulation and human disease, to facilitate the development of the drugs to treat diseases caused by the abnormalities in this process, and to train the next generation of the scientists who will advance the subject. In SCILLS we have Ubiquitome specific custom library of Dharmacon ON-TARGETplus SMARTpool siRNAs. 

The Dundee Drug Discovery Unit (DDU) was founded in 2006 in the College of Life Sciences, University of Dundee, with the aim of translating basic science into lead compounds to validate putative drug targets, to use as tools to investigate disease pathways and, when appropriate, advance to pre-clinical drug candidates. The DDU works to Biotech style philosophy and standards incorporating, dynamic, goal driven Project Management based on Target Product Profiles and Compound Selection Criteria.  

The DDU has all of the capabilities required for early phase drug discovery: assay development, high throughput screening, cell biology, medicinal chemistry, structural biology, computational chemistry and DMPK. All of these capabilities operate under one management structure to ensure an integrated approach and rapid progress. 

The DDU holds and manages use and access to the Dharmacon genome -wide siGENOME SMARTpool siRNA collection 

For more information on SCILLS & DDU please visit our website at: www.scills.ac.uk , http://www.drugdiscovery.dundee.ac.uk/index.html 

RNAi Global Principal Investigators: 

Ronald T. Hay  

Professor of Molecular Biology 

Email 

Primary Contact: 

Amit K Garg 

Informatics Data Manager 

Email